David Adlam

Showing 1-3 of 3 articles

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Long-term follow-up of spontaneous coronary artery dissection treated with bioresorbable scaffolds

Macaya F, Salinas P, Gonzalo N, Camacho-Freire SJ, Jackson R, Massot M, Ortas-Nadal MR, Sanchez Recalde A, Diaz-Fernandez J, Moreu J, Adlam D, Escaned J

January 18, 2019 | 10.4244/EIJ-D-18-00519

Editorial on: “Characteristics of extension and de novo recurrent spontaneous coronary artery dissection”

Adlam D, Wood A, Al-Hussaini A

December 8, 2017 | 10.4244/EIJV13I12A220

1

Latest news

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

January 20, 2021

The Year in Review

January 22, 2021

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Moving (re-shaping) the mitral annulus

January 20, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Use of intravascular OCT or IVUS to guide stent implantation.

January 20, 2021

Last Week's JAA's: TTVr with the TriClip/MitraClip G4 System and much more...

January 12, 2021

Valvular disease